- Home
- ZCMD vs CRIS Comparison
ZCMD vs CRIS Comparison
Compare ZCMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- CRIS
- Stock Information
- Founded
- ZCMD 2012
- CRIS 2000
- Country
- ZCMD China
- CRIS United States
- Employees
- ZCMD N/A
- CRIS N/A
- Industry
- ZCMD Other Consumer Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZCMD Real Estate
- CRIS Health Care
- Exchange
- ZCMD Nasdaq
- CRIS Nasdaq
- Market Cap
- ZCMD 35.3M
- CRIS 32.8M
- IPO Year
- ZCMD 2020
- CRIS 2000
- Fundamental
- Price
- ZCMD $1.45
- CRIS $3.22
- Analyst Decision
- ZCMD
- CRIS Strong Buy
- Analyst Count
- ZCMD 0
- CRIS 3
- Target Price
- ZCMD N/A
- CRIS $23.00
- AVG Volume (30 Days)
- ZCMD 6.1K
- CRIS 37.6K
- Earning Date
- ZCMD 01-01-0001
- CRIS 02-18-2025
- Dividend Yield
- ZCMD N/A
- CRIS N/A
- EPS Growth
- ZCMD N/A
- CRIS N/A
- EPS
- ZCMD N/A
- CRIS N/A
- Revenue
- ZCMD $17,406,104.00
- CRIS $10,259,000.00
- Revenue This Year
- ZCMD N/A
- CRIS N/A
- Revenue Next Year
- ZCMD N/A
- CRIS N/A
- P/E Ratio
- ZCMD N/A
- CRIS N/A
- Revenue Growth
- ZCMD 1.01
- CRIS 0.44
- 52 Week Low
- ZCMD $1.00
- CRIS $2.86
- 52 Week High
- ZCMD $5.10
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- ZCMD 44.73
- CRIS 47.34
- Support Level
- ZCMD $1.34
- CRIS $3.05
- Resistance Level
- ZCMD $1.51
- CRIS $3.55
- Average True Range (ATR)
- ZCMD 0.11
- CRIS 0.24
- MACD
- ZCMD 0.01
- CRIS 0.03
- Stochastic Oscillator
- ZCMD 39.66
- CRIS 47.53
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.